<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><title>SEC FORM 
            3</title><style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style></head><body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr><td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td><td rowspan="1" width="60%" valign="middle" align="center"><span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span></td><td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box"><tr><td class="FormTextC">OMB APPROVAL</td></tr><tr><td><table width="100%" border="0" summary="OMB Interior Box"><tr><td class="SmallFormText" colspan="3">OMB Number:</td><td class="SmallFormTextR">3235-0104</td></tr><tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr><tr><td class="SmallFormText" colspan="3">hours per response:</td><td class="SmallFormTextR">0.5</td></tr></table></td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><tr><td rowspan="3" width="30%" valign="top"><span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001971205">Yang Yuanqing</a></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(Last)</td><td width="33%" class="MedSmallFormText">(First)</td><td width="33%" class="MedSmallFormText">(Middle)</td></tr></table><table border="0" width="100%"><tr><td><span class="FormData">NO. 10 SHANGDI 10TH STREET</span></td></tr><tr><td><span class="FormData"></span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr><td width="33%"><span class="FormData">BEIJING</span></td><td width="33%"><span class="FormData"><span class="FormData">CHINA</span></span></td><td width="33%"><span class="FormData">100085</span></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(City)</td><td width="33%" class="MedSmallFormText">(State)</td><td width="33%" class="MedSmallFormText">(Zip)</td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" colspen="3"><span class="FormData">
				CHINA
			</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Country)</span></td><td rowspan="3" width="15%" valign="top"><span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">03/18/2026</span></td><td valign="top" colspan="2"><span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001329099">Baidu, Inc.</a>
     [ <span class="FormData">BIDU</span> ]
   </td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">3a. Foreign Trading Symbol
		 <br></span></td><td valign="top"><span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br></td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%"><tr><td width="15%" align="center"><span class="FormData">X</span></td><td width="35%" class="MedSmallFormText">Director</td><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">10% Owner</td></tr><tr><td align="center"></td><td class="MedSmallFormText">Officer (give title below)</td><td align="center"></td><td class="MedSmallFormText">Other (specify below)</td></tr><tr><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue"></td><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue"></td></tr></table></td><td valign="top"><span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%"><tr><td width="15%" align="center"><span class="FormData">X</span></td><td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td></tr><tr><td width="15%" align="center"></td><td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr><tr><th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th><th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th><th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr></thead><tbody><tr><td align="left"><span class="FormData">Class A ordinary shares</span><span class="FootnoteData"><sup>(1)</sup></span></td><td align="center"><span class="FormData">119,336</span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr></tbody></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC"><b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b></th></tr><tr><th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th><th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th><th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th><th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th><th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr><tr><th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th><th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th><th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th><th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th></tr></thead><tbody><tr><td align="left"><span class="FormData">Restricted Shares</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A ordinary shares</span></td><td align="center"><span class="FormData">28,728</span></td><td align="center"><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr></tbody></table><table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr><tr><td class="FootnoteData">1. The Class A ordinary shares are held in the form of American depositary shares. Each American depositary share represents eight Class A ordinary shares.</td></tr><tr><td class="FootnoteData">2. Represents restricted shares granted on February 6, 2026. The restricted shares vest per annum in four equal installments over a 2-year period, starting from the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date. The restricted shares do not have an expiration date.</td></tr></table><table width="100%" border="0"><tr><td width="60%"></td><td width="20%"><u><span class="FormData">/s/ Yuanqing Yang</span></u></td><td width="20%"><u><span class="FormData">03/18/2026</span></u></td></tr><tr><td></td><td class="MedSmallFormText">** Signature of Reporting Person</td><td class="MedSmallFormText">Date</td></tr><tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr><tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr><tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr><tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr><tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr><tr><td colspan="3" class="MedSmallFormText"><b>* Form 3: SEC 1473 (03-26)</b></td></tr></table></body></html>
